|
US20070021493A1
(en)
|
1999-09-16 |
2007-01-25 |
Curis, Inc. |
Mediators of hedgehog signaling pathways, compositions and uses related thereto
|
|
US7230000B1
(en)
|
1999-10-27 |
2007-06-12 |
Cytokinetics, Incorporated |
Methods and compositions utilizing quinazolinones
|
|
US7671200B2
(en)
*
|
1999-10-27 |
2010-03-02 |
Cytokinetics, Inc. |
Quinazolinone KSP inhibitors
|
|
US6545004B1
(en)
*
|
1999-10-27 |
2003-04-08 |
Cytokinetics, Inc. |
Methods and compositions utilizing quinazolinones
|
|
US7115653B2
(en)
|
2000-03-30 |
2006-10-03 |
Curis, Inc. |
Small organic molecule regulators of cell proliferation
|
|
US8852937B2
(en)
|
2000-03-30 |
2014-10-07 |
Curis, Inc. |
Small organic molecule regulators of cell proliferation
|
|
US6964967B2
(en)
*
|
2000-12-11 |
2005-11-15 |
Amgen, Inc. |
Substituted pyrido[2,3-d]pyrimidines and methods for their use
|
|
US6469002B1
(en)
*
|
2001-04-19 |
2002-10-22 |
Millennium Pharmaceuticals, Inc. |
Imidazolidine compounds
|
|
US6794379B2
(en)
|
2001-06-06 |
2004-09-21 |
Tularik Inc. |
CXCR3 antagonists
|
|
WO2003018549A2
(en)
*
|
2001-08-30 |
2003-03-06 |
Chemocentryx, Inc. |
Bicyclic compounds as inhibitors of chemokine binding to us28
|
|
ATE469648T1
(de)
*
|
2001-09-05 |
2010-06-15 |
Minerva Biotechnologies Corp |
Zusammensetzungen und deren verwendung zur behandlung von krebs
|
|
US6753428B2
(en)
*
|
2001-11-20 |
2004-06-22 |
Cytokinetics, Inc. |
Process for the racemization of chiral quinazolinones
|
|
WO2003070701A2
(en)
*
|
2002-02-15 |
2003-08-28 |
Cytokinetics, Inc. |
Syntheses of quinazolinones
|
|
ES2361403T3
(es)
|
2002-03-07 |
2011-06-16 |
X-Ceptor Therapeutics, Inc. |
Moduladores de quinazolinona de receptores nucleares.
|
|
US7381730B2
(en)
*
|
2002-03-15 |
2008-06-03 |
Bristol-Myers Squibb Company |
3-arylquinazoline derivatives as selective estrogen receptor beta modulators
|
|
US20050119174A1
(en)
*
|
2002-04-03 |
2005-06-02 |
Sumitomo Pharmaceuticals Co. Ltd. |
Novel blood sugar controller and method of screening the same
|
|
WO2003084544A2
(en)
*
|
2002-04-04 |
2003-10-16 |
Cv Therapeutics, Inc. |
Compounds dor increasing abca-1 expression useful for treating coronary artery disease and atherosclerosis
|
|
US20030225288A1
(en)
*
|
2002-04-12 |
2003-12-04 |
Millennium Pharmaceuticals, Inc. |
Imidazolidine compounds
|
|
ATE471931T1
(de)
|
2002-04-17 |
2010-07-15 |
Cytokinetics Inc |
Verbindungen, zusammensetzungen und verfahren
|
|
WO2003094839A2
(en)
*
|
2002-05-09 |
2003-11-20 |
Cytokinetics, Inc. |
Pyrimidinone compounds, compositions and methods
|
|
AU2003270015A1
(en)
|
2002-05-09 |
2003-12-02 |
Cytokinetics, Inc. |
Compounds, compositions, and methods
|
|
JP2005536475A
(ja)
*
|
2002-05-23 |
2005-12-02 |
サイトキネティクス・インコーポレーテッド |
化合物、組成物、および方法
|
|
EP1507756B1
(en)
*
|
2002-05-24 |
2015-07-22 |
Millennium Pharmaceuticals, Inc. |
Ccr9 inhibitors and methods of use thereof
|
|
EP1556357A4
(en)
*
|
2002-06-14 |
2006-09-13 |
Cytokinetics Inc |
COMPOUNDS, COMPOSITIONS AND METHODS
|
|
WO2004006865A2
(en)
|
2002-07-17 |
2004-01-22 |
Cytokinetics, Inc. |
Compounds, compositions, and methods
|
|
EP1537089A4
(en)
|
2002-07-23 |
2008-04-16 |
Cytokinetics Inc |
CONNECTIONS, COMPOSITIONS AND PROCEDURES
|
|
AU2003262747A1
(en)
*
|
2002-08-21 |
2004-03-11 |
Cytokinetics, Inc. |
Compounds, compositions, and methods
|
|
JP2005539062A
(ja)
*
|
2002-09-13 |
2005-12-22 |
サイトキネティクス・インコーポレーテッド |
化合物、組成物および方法
|
|
EP1558083A4
(en)
*
|
2002-09-30 |
2008-04-16 |
Cytokinetics Inc |
COMPOUNDS, COMPOSITIONS AND METHODS
|
|
CA2500952C
(en)
|
2002-10-04 |
2011-04-26 |
Prana Biotechnology Limited |
Neurologically-active compounds
|
|
US20040242568A1
(en)
*
|
2003-03-25 |
2004-12-02 |
Syrrx, Inc. |
Dipeptidyl peptidase inhibitors
|
|
WO2004092123A2
(en)
*
|
2003-04-10 |
2004-10-28 |
Microbia, Inc. |
Inhibitors of fungal invasion
|
|
WO2005042697A2
(en)
*
|
2003-10-06 |
2005-05-12 |
Cytokinetics, Inc. |
Compounds, compositions and methods
|
|
WO2005041888A2
(en)
*
|
2003-11-03 |
2005-05-12 |
Cytokinetics, Inc. |
Pyrimidin-4-one compounds, compositions and methods
|
|
US20050148593A1
(en)
*
|
2003-11-07 |
2005-07-07 |
Gustave Bergnes |
Compounds, compositions, and methods
|
|
JP2007513154A
(ja)
|
2003-12-08 |
2007-05-24 |
サイトキネティクス・インコーポレーテッド |
化合物、組成物及び方法
|
|
CA2558813A1
(en)
*
|
2004-03-09 |
2005-09-15 |
Kyoto University |
Pharmaceutical composition comprising cxcr3 inhibitor
|
|
MXPA06011236A
(es)
|
2004-04-02 |
2007-01-16 |
Prana Biotechnology Ltd |
Compuestos neurologicamente activos.
|
|
US7939538B2
(en)
*
|
2004-06-28 |
2011-05-10 |
Amgen Inc. |
Compounds, compositions and methods for prevention and treatment of inflammatory and immunoregulatory disorders and diseases
|
|
US7271271B2
(en)
|
2004-06-28 |
2007-09-18 |
Amgen Sf, Llc |
Imidazolo-related compounds, compositions and methods for their use
|
|
US7375102B2
(en)
*
|
2004-06-28 |
2008-05-20 |
Amgen Sf, Llc |
Tetrahydroquinazolin-4(3H)-one-related and tetrahydropyrido[2,3-D]pyrimidin-4(3H)-one-related compounds, compositions and methods for their use
|
|
EP1786265A4
(en)
*
|
2004-08-30 |
2009-08-19 |
Smithkline Beecham Corp |
NEW COMPOSITIONS AND PROCESSING METHODS
|
|
KR101231466B1
(ko)
|
2004-09-13 |
2013-02-07 |
오노 야꾸힝 고교 가부시키가이샤 |
질소 함유 복소환 유도체 및 이들을 유효 성분으로 하는약제
|
|
US20080096859A1
(en)
*
|
2004-10-01 |
2008-04-24 |
Sullivan Kathleen A |
Compositions and Methods for Treating Ophthalmic Diseases
|
|
US9512125B2
(en)
|
2004-11-19 |
2016-12-06 |
The Regents Of The University Of California |
Substituted pyrazolo[3.4-D] pyrimidines as anti-inflammatory agents
|
|
EP1889622A4
(en)
|
2005-05-31 |
2009-12-23 |
Ono Pharmaceutical Co |
SPIROPIPERIDINE COMPOUND AND MEDICINAL USE THEREOF
|
|
ATE474829T1
(de)
*
|
2005-06-27 |
2010-08-15 |
Amgen Inc |
Entzündungshemmende arylnitrilverbindungen
|
|
US20100267633A1
(en)
*
|
2005-09-26 |
2010-10-21 |
Barbara Hanney |
N-(4-Oxo-3,4-Dihydroquinazolin-2Yl) Butanamides as Androgen Receptor Modulators
|
|
JPWO2007105637A1
(ja)
|
2006-03-10 |
2009-07-30 |
小野薬品工業株式会社 |
含窒素複素環誘導体およびそれらを有効成分とする薬剤
|
|
KR101499783B1
(ko)
|
2006-04-04 |
2015-03-09 |
더 리젠트스 오브 더 유니이버시티 오브 캘리포니아 |
키나제 길항물질
|
|
US20100144693A1
(en)
|
2006-04-14 |
2010-06-10 |
Prana Biotechnology Limited |
Method of treatment of age-related macular degeneration (amd)
|
|
WO2008016006A1
(fr)
|
2006-07-31 |
2008-02-07 |
Ono Pharmaceutical Co., Ltd. |
Composé auquel un groupe cyclique est lié par une liaison spiro et son utilisation
|
|
CA2659632A1
(en)
*
|
2006-08-01 |
2008-02-07 |
Applera Corporation |
Detection of analytes and nucleic acids
|
|
JP2010505811A
(ja)
*
|
2006-10-04 |
2010-02-25 |
ファイザー・プロダクツ・インク |
カルシウム受容体アンタゴニストとしてのピリド［４，３−ｄ］ピリミジン−４（３Ｈ）−オン誘導体
|
|
WO2008057468A1
(en)
|
2006-11-02 |
2008-05-15 |
Curis, Inc. |
Small organic molecule regulators of cell proliferation
|
|
WO2008085828A2
(en)
*
|
2007-01-03 |
2008-07-17 |
The Johns Hopkins University |
Peptide modulators of angiogenesis and use thereof
|
|
US20110160232A1
(en)
|
2007-10-04 |
2011-06-30 |
Pingda Ren |
Certain chemical entities and therapeutic uses thereof
|
|
US8193182B2
(en)
|
2008-01-04 |
2012-06-05 |
Intellikine, Inc. |
Substituted isoquinolin-1(2H)-ones, and methods of use thereof
|
|
AU2009204483B2
(en)
|
2008-01-04 |
2014-03-13 |
Intellikine, Llc |
Certain chemical entities, compositions and methods
|
|
US8993580B2
(en)
|
2008-03-14 |
2015-03-31 |
Intellikine Llc |
Benzothiazole kinase inhibitors and methods of use
|
|
JP5547099B2
(ja)
|
2008-03-14 |
2014-07-09 |
インテリカイン， エルエルシー |
キナーゼ阻害剤および使用方法
|
|
US20110224223A1
(en)
|
2008-07-08 |
2011-09-15 |
The Regents Of The University Of California, A California Corporation |
MTOR Modulators and Uses Thereof
|
|
MX2011000216A
(es)
|
2008-07-08 |
2011-03-29 |
Intellikine Inc |
Inhibidores de cinasa y metodos para su uso.
|
|
WO2010036380A1
(en)
|
2008-09-26 |
2010-04-01 |
Intellikine, Inc. |
Heterocyclic kinase inhibitors
|
|
WO2010045542A2
(en)
|
2008-10-16 |
2010-04-22 |
The Regents Of The University Of California |
Fused ring heteroaryl kinase inhibitors
|
|
US8476431B2
(en)
|
2008-11-03 |
2013-07-02 |
Itellikine LLC |
Benzoxazole kinase inhibitors and methods of use
|
|
WO2010129351A1
(en)
|
2009-04-28 |
2010-11-11 |
Schepens Eye Research Institute |
Method to identify and treat age-related macular degeneration
|
|
WO2010129816A2
(en)
|
2009-05-07 |
2010-11-11 |
Intellikine, Inc. |
Heterocyclic compounds and uses thereof
|
|
WO2011047384A2
(en)
|
2009-10-16 |
2011-04-21 |
The Regents Of The University Of California |
Methods of inhibiting ire1
|
|
JP5951600B2
(ja)
|
2010-05-21 |
2016-07-13 |
インフィニティー ファーマシューティカルズ， インコーポレイテッド |
キナーゼ調節のための、化合物、組成物および方法
|
|
US8901133B2
(en)
|
2010-11-10 |
2014-12-02 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
|
KR20180080358A
(ko)
|
2011-01-10 |
2018-07-11 |
인피니티 파마슈티칼스, 인코포레이티드 |
이소퀴놀린온 및 이의 고체 형태의 제조 방법
|
|
JP6130305B2
(ja)
|
2011-02-23 |
2017-05-17 |
インテリカイン， エルエルシー |
キナーゼ阻害剤の組み合わせおよびそれらの使用
|
|
EP2734530A1
(en)
|
2011-07-19 |
2014-05-28 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
|
CN103930422A
(zh)
|
2011-07-19 |
2014-07-16 |
无限药品股份有限公司 |
杂环化合物及其用途
|
|
CN103998442B
(zh)
|
2011-08-29 |
2016-09-14 |
无限药品股份有限公司 |
杂环化合物及其用途
|
|
MX370814B
(es)
|
2011-09-02 |
2020-01-08 |
Univ California |
Pirazolo[3,4-d]pirimidinas sustituidas y usos de las mismas.
|
|
US8940742B2
(en)
|
2012-04-10 |
2015-01-27 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
|
US8828998B2
(en)
|
2012-06-25 |
2014-09-09 |
Infinity Pharmaceuticals, Inc. |
Treatment of lupus, fibrotic conditions, and inflammatory myopathies and other disorders using PI3 kinase inhibitors
|
|
WO2014052669A1
(en)
|
2012-09-26 |
2014-04-03 |
The Regents Of The University Of California |
Modulation of ire1
|
|
IL291945B2
(en)
|
2012-11-01 |
2025-11-01 |
Infinity Pharmaceuticals Inc |
Treatment of cancers using pi3 kinase isoform modulators
|
|
US9481667B2
(en)
|
2013-03-15 |
2016-11-01 |
Infinity Pharmaceuticals, Inc. |
Salts and solid forms of isoquinolinones and composition comprising and methods of using the same
|
|
MX389256B
(es)
|
2013-10-04 |
2025-03-20 |
Infinity Pharmaceuticals Inc |
Compuestos heterociclicos y usos de los mismos.
|
|
WO2015051241A1
(en)
|
2013-10-04 |
2015-04-09 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
|
EP4066834A1
(en)
|
2014-03-19 |
2022-10-05 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds for use in the treatment of pi3k-gamma mediated disorders
|
|
AR099789A1
(es)
*
|
2014-03-24 |
2016-08-17 |
Actelion Pharmaceuticals Ltd |
Derivados de 8-(piperazin-1-il)-1,2,3,4-tetrahidro-isoquinolina
|
|
US20150320755A1
(en)
|
2014-04-16 |
2015-11-12 |
Infinity Pharmaceuticals, Inc. |
Combination therapies
|
|
WO2016054491A1
(en)
|
2014-10-03 |
2016-04-07 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
|
CN108349985A
(zh)
|
2015-09-14 |
2018-07-31 |
无限药品股份有限公司 |
异喹啉酮的固体形式、其制备方法、包含其的组合物及其使用方法
|
|
US10759806B2
(en)
|
2016-03-17 |
2020-09-01 |
Infinity Pharmaceuticals, Inc. |
Isotopologues of isoquinolinone and quinazolinone compounds and uses thereof as PI3K kinase inhibitors
|
|
WO2017214269A1
(en)
|
2016-06-08 |
2017-12-14 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
|
CA3028718A1
(en)
|
2016-06-24 |
2017-12-28 |
Infinity Pharmaceuticals, Inc. |
Combination therapies
|
|
JP7630801B2
(ja)
*
|
2020-07-13 |
2025-02-18 |
国立大学法人富山大学 |
Ｎｒ４ａ１拮抗薬を用いた鎮痛薬
|
|
WO2022040606A1
(en)
*
|
2020-08-20 |
2022-02-24 |
Seattle Children's Hospital D/B/A Seattle Children's Research Institute |
Compositions and methods to reduce neuroinflammation
|